Accentia Biopharmace (ABPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2012 | 09-2011 | 09-2010 | 09-2009 | 09-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 129 | 421 | 559 | 325 | 1,229 |
| Receivables | 284 | 1,345 | 1,439 | 3,029 | 4,012 |
| Inventories | 400 | 532 | 417 | 509 | 609 |
| Other current assets | 9 | 398 | 16 | 0 | 1,613 |
| TOTAL | $1,004 | $2,867 | $2,674 | $4,248 | $7,978 |
| Non-Current Assets | |||||
| PPE Net | 965 | 796 | 142 | 332 | 913 |
| Intangibles | 4 | 13 | 1,977 | 3,827 | 5,579 |
| Other Non-Current Assets | 610 | 2,237 | 217 | 1,430 | 1,841 |
| TOTAL | $1,580 | $3,047 | $2,336 | $5,588 | $8,334 |
| Total Assets | $2,584 | $5,914 | $5,010 | $9,836 | $16,312 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 47,320 | 20,233 | 1,140 | N/A | 27,126 |
| Accounts payable and accrued liabilities | 1,176 | 863 | 0 | 1,532 | 8,671 |
| Accrued Expenses | 6,424 | 978 | 1,269 | 2,211 | 3,216 |
| Other current liabilities | 1,044 | 8,855 | 1,979 | 209 | 25,428 |
| TOTAL | $55,965 | $31,269 | $6,693 | $6,239 | $87,310 |
| Non-Current Liabilities | |||||
| Long Term Debt | 13,268 | 42,265 | N/A | N/A | 1,972 |
| Deferred Revenues | N/A | N/A | 264 | 956 | 1,218 |
| Other Non-Current Liabilities | 17,954 | 23,540 | 151,511 | 103,811 | 27,348 |
| TOTAL | $26,356 | $61,705 | $151,099 | $103,811 | $29,320 |
| Total Liabilities | $82,321 | $92,973 | $157,792 | $110,050 | $116,630 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 89,756 | 75,238 | 69,601 | 58,048 | 58,048 |
| Common Shares | 90 | 75 | 58 | 58 | 54 |
| Retained earnings | -338,193 | -333,870 | -325,883 | -277,839 | -301,146 |
| Other shareholders' equity | -17,104 | -12,994 | -30,785 | -27,533 | -170 |
| TOTAL | $-79,737 | $-87,059 | $-152,781 | $-100,214 | $-100,318 |
| Total Liabilities And Equity | $2,584 | $5,914 | $5,010 | $9,836 | $16,312 |